Nicolas Jendly Email & Phone Number
@seagen.com
LinkedIn matched
Who is Nicolas Jendly? Overview
A concise factual answer block for searchers comparing this professional profile.
Nicolas Jendly is listed as Vice President Finance and Operations, Europe at Revolution Medicines, a with 737 employees, based in Neuchâtel, Switzerland. AeroLeads shows a work email signal at seagen.com and a matched LinkedIn profile for Nicolas Jendly.
Nicolas Jendly previously worked as Vice President Finance and Operations, International at Cabaletta Bio and Vice President International Finance at Seagen. Nicolas Jendly holds Cpa / Expertise Comptable from Académie Suisse D'Experts Comptables.
Email format at Revolution Medicines
This section adds company-level context without repeating Nicolas Jendly's masked contact details.
AeroLeads found 1 current-domain work email signal for Nicolas Jendly. Compare company email patterns before reaching out.
About Nicolas Jendly
I am a versatile (Finance, Operations, Commercial), creative and motivating Biotech leader, experienced in building and developing teams to capture and grow new business opportunities. Strongly believing in the social benefits of medical innovation, I strive to contribute to a healthcare ecosystem continuously improving patients’ lives.Over the last 20 years, my professional path has been marked out by various functional and geographical roles that have contributed to shaping me as a polyvalent and agile Biotech leader:-
Listed skills include Internal Controls, Management, Finance, Accounting, and 22 others.
Nicolas Jendly's current company
Company context helps verify the profile and gives searchers a useful next step.
Nicolas Jendly work experience
A career timeline built from the work history available for this profile.
Vice President Finance And Operations, International
Vice President International Finance
Lead Seagen International Finance organization. Advise on and implement Seagen International expansion strategy (Commercial, Development, Supply Chain & Logistics)
Head Of International Finance
Vice President Finance And Operations - Europe
Together with the Senior VP Europe – prepare, present, defend and implement the Go-to-market strategy in EU enabling Portola to establish a rapid presence in a selection of key EU countries and launch Ondexxya® with a pan-european and cross-functional team of 50+ people
Excecutive Director Finance And Operations - Europe
Executive Director - Information Knowledge Utilization (Iku) - Emea
Building and Leading Celgene's EMEA Centre of Excellence for information Knowledge Utilization (iKU) activities - Transforming the way Celgene Think, Act and Lead with Big Data and Data Science; Change Management consisting of:A/ Recruiting Team and implementing iKU EMEA operating modelB/ Creating an EMEA wide network of "believers" enabling the change towards a new data-driven mindset in each of Celgene's affiliates and functionsC/ Driving adoption of the Company's Big Data connective platform and demonstrating the "Art of the Possible" during a pan-European roadshow impacting 800+ peopleD/ Facilitating the acquisition of strategic external datasets and delivering on tangible use cases generating key insights throughout the products' lifecycle and leveraging the new Data Science capabilityE/ Influencing and contributing to external Big Data / Data Science healthcare stakeholders (OHDSI, IMI- EHDEN, Academics Cooperative Group, etc.)
Sr Commercial Director - Lymphoma & Cll - Emea
Design and execute on the EMEA “go-to market” sales and product marketing strategy of the Lymphoma portfolio:- Synergize effort with Medical Affairs and Market Access Teams to secure launch readiness of our brands in Mantle Cell Lymphoma, Follicular Lymphoma, and Diffuse Large B-Cell Lymphoma- Develop and deliver on the EMEA 3 Years Lymphoma Operating Plan and 5 years Long Range Plan to secure mid/long-term funding. - Lead Key Opinion Leaders engagement plan- Develop EU strategy mitigating the risk of price erosion of launching new indications connected to an already reimbursed brand
Senior Director, Finance, Hematology & Oncology Emea
Provide strategic and financial guidance to the Corporate VP EMEA Hematology/Oncology Franchise in order to deliver and execute on the regional franchise P&L (multi-billion $ from 30+ affiliates):• Lead the Hem/Onc Finance and Business Planning HQ Team (5 people) and guide the EMEA Finance community (30 people) to deliver on a consolidated regional franchise P&L achieving a double-digit Revenue and Profitability % growth• Design and implement the EMEA budget cycle and quarterly forecast process (latest estimate) • Calibrate and set Revenue and OPEX targets for the EMEA markets. Introduce flexibility for one-off opportunities (business cases) allowing for an agile resource allocation accelerating revenue growth• Lead the EMEA Hem/Onc Long Range Plan process (5y/10y) by collecting input from Commercial, Medical Affairs, and Market Access Teams. Present findings and recommendations to Global Leadership Team
Director Finance, South Europe Region
Director Finance And Business Planning
As a founding core team member of Celgene China; setup, develop and Lead the Finance & IT organization enabling the affiliate to sustainably grow the newly established business:- Overcome the Financial and Cultural challenges of the integration of the newly acquired local Chinese affiliate (80 people), marking Celgene’s first footprint in China- In a highly uncertain and risky environment, secure proper funding from Regional HQ to grow the solid tumor business and launch Celgene’s flagship product in China- Lead cross-functional taskforce assessing Celgene’s long-term strategic options in China (manufacturing, R&D, partnerships, JV, etc.)- Build and implement the internal control environment resulting in a compliant and accurate accounting (US and local GAAP), VAT and tax reporting
Associate Director Finance
Co-lead the International Shared Service Center Accounting Team (20+ people), covering General Ledger, Accounts Payable/Receivable, Tax /VAT Returns activities:- Supervise US GAAP close-the-books activities for 40+ legal entities and the timely completion of the local Statutory Accounts- Partner with US headquarter Tax and Treasury experts, internal and external auditors and Worldwide Finance Directors to comply with local and US reporting requirements- Project lead in implementing Global process improvements and platforms (e.g. Oracle “Accounts Payable » module, Concur Travel Expense management system)
Senior Manager Finance
Accounting Manager
Senior Accountant
Assistant Manager (Sr. Accountant - Accountant)
Team Lead in auditing Financial Statements (including Group Consolidated) complying with accounting principles such as IFRS, US-GAAP, Swiss GAAP RPC, Swiss “Code des obligations”:- Team lead in auditing first-time application of the Sarbanes-Oxley Act (SOX 404) procedures- Consultant on specific agreed-upon procedures (egg. Evaluation of assets, Fraud investigation)
Colleagues at Revolution Medicines
Other employees you can reach at revolutionmedicines.com. View company contacts for 737 employees →
Rick Homan
Colleague at Revolution MedicinesRedwood City, California, United States
View →
EC
Eric Churchill
Colleague at Revolution MedicinesLos Angeles Metropolitan Area, United States
View →
NW
Nikita Walker
Colleague at Revolution MedicinesRedwood City, California, United States
View →
AP
Anna Pham
Colleague at Revolution MedicinesOakland, California, United States
View →
DP
Dylan Parsons
Colleague at Revolution MedicinesSan Francisco Bay Area, United States
View →
FY
Frances Y. Zhao
Colleague at Revolution MedicinesSan Francisco Bay Area, United States
View →
VW
Victoria Woodland
Colleague at Revolution MedicinesCary, North Carolina, United States
View →
JB
James Bennett, Mfa
Colleague at Revolution MedicinesSan Diego, California, United States
View →
JW
John Wacker
Colleague at Revolution MedicinesMaitland, Florida, United States
View →
LT
Linh Tran
Colleague at Revolution MedicinesSan Jose, California, United States
View →
Nicolas Jendly education
Cpa / Expertise Comptable
Master'S Degree, Finance
Master’S Degree, Economics & Finance
Master'S Degree, Finance, General
Frequently asked questions about Nicolas Jendly
Quick answers generated from the profile data available on this page.
What company does Nicolas Jendly work for?
Nicolas Jendly works for Revolution Medicines.
What is Nicolas Jendly's role at Revolution Medicines?
Nicolas Jendly is listed as Vice President Finance and Operations, Europe at Revolution Medicines.
What is Nicolas Jendly's email address?
AeroLeads has found 1 work email signal at @seagen.com for Nicolas Jendly at Revolution Medicines.
Where is Nicolas Jendly based?
Nicolas Jendly is based in Neuchâtel, Switzerland while working with Revolution Medicines.
What companies has Nicolas Jendly worked for?
Nicolas Jendly has worked for Revolution Medicines, Cabaletta Bio, Seagen, Portola Pharmaceuticals, and Celgene.
Who are Nicolas Jendly's colleagues at Revolution Medicines?
Nicolas Jendly's colleagues at Revolution Medicines include Rick Homan, Eric Churchill, Nikita Walker, Anna Pham, and Dylan Parsons.
How can I contact Nicolas Jendly?
You can use AeroLeads to view verified contact signals for Nicolas Jendly at Revolution Medicines, including work email, phone, and LinkedIn data when available.
What schools did Nicolas Jendly attend?
Nicolas Jendly holds Cpa / Expertise Comptable from Académie Suisse D'Experts Comptables.
What skills is Nicolas Jendly known for?
Nicolas Jendly is listed with skills including Internal Controls, Management, Finance, Accounting, Strategy, Auditing, Ifrs, and Business Planning.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialCheck these profiles if this is not the Nicolas Jendly you were looking for.
View similar profiles